Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-06-07
2005-06-07
Huang, Evelyn Mei (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S112000, C546S023000
Reexamination Certificate
active
06903111
ABSTRACT:
An isoquinuclidine derivative represented by the following general formula (I): (I) [wherein A1is methylene or carbonyl]: R1is hydrogen or methyl: R2is —(CH2)n-A2-Ph (n is an integer of 0 to 3 and A2is a single bond or —O—): and R3is —COOH, —COOR4, —COSR4(R4is lower alkyl, unsubstituted phenyl, or phenyl substituted by a lower alkyl, lower alkoxy, hydroxyl, methoxycarbonyl, ethoxycarbonyl, or trifluoromethanesulfonamide group or by a halogen atom), etc.] or a pharmaceutically acceptable salt of the compound. Also provided is an oral remedy for diabetes, which contains the compound and has hypoglycemic activity.
REFERENCES:
patent: 3535313 (1970-10-01), Dietrich
patent: 4028364 (1977-06-01), Adelstein
patent: 4134890 (1979-01-01), Yonan
patent: 4959372 (1990-09-01), Vincent et al.
patent: 5019580 (1991-05-01), Iwu
patent: 5021425 (1991-06-01), Teisseire
patent: WO 01/15673 (2001-03-01), None
Kobayashi Yoshinori
Noda Atsushi
Tomiyama Hiroshi
Huang Evelyn Mei
Kotobuki Pharmaceutical Co. Ltd.
Sherman & Shalloway
LandOfFree
Isoquinuclidine derivative process for producing the same,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isoquinuclidine derivative process for producing the same,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isoquinuclidine derivative process for producing the same,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3507628